Biosensing technology is becoming increasingly amenable for consumer applications. What are existing R&D and distribution limitations and how may these be addressed over the next few years? How do we see future applications being adopted by consumers in multiple contexts?
- Chair: Corinna E. Lathan, Founder and CEO of AnthroTronix, YGL Class of 2006
- Stanley Yang, CEO of NeuroSky
- Deborah Rozman, CEO of HeartMath
- Ariel Garten, CEO of InteraXon
This session took place at the 2013 SharpBrains Virtual Summit: http://sharpbrains.com/summit-2013/agenda/